Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
Objectives This post-hoc analysis explored the impact of body mass index (BMI) on tofacitinib efficacy/safety in patients with active psoriatic arthritis (PsA).Methods Data were pooled from two phase 3 studies (NCT01877668; NCT01882439). Analyses included patients randomised to tofacitinib 5/10 mg...
Sparad:
| Huvudupphov: | , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMJ Publishing Group
2021-04-01
|
| Serie: | RMD Open |
| Länkar: | https://rmdopen.bmj.com/content/7/1/e001486.full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|